Other ways to fundraise

Get active for a cure!

The Fit4Change app allows you to raise free funds for CPT as they donate 5p to CPT’s pioneering Parkinson’s research with every mile you run, walk or cycle. Read more

AmazonSmile is the same Amazon you know: same products, same prices and the same service. However this exciting new scheme allows you to support The Cure Parkinson's Trust through your Amazon shop, at no extra cost to you. Read more

Social Media Fundraising

Fundraising on social media is a fantastic way to raise awareness for the ground-breaking research we do here at The Cure Parkinson’s Trust (CPT). Read more

eBay4Charity

Over 2 million people each year give to UK charities when they buy or sell on eBay and you could be one of them! Through eBay4Charity you can easily sell your unwanted goods and turn them into a donation for The Cure Parkinson’s Trust. Read more

Give as you Live

Give as you Live is a shopping and price comparison website which allows you to support The Cure Parkinson's Trust's pioneering research. Read more

Bag2TheFuture

Get together with family, friends, neighbours or your school and recycle for a cure! Read more

Recycle4Charity

Recycle4Charity provides a free, easy and environmentally friendly way for you to recycle your empty printer inkjet cartridges whilst supporting the The Cure Parkinson's Trust. Read more

Give a Car

Do you have an old unused car – that’s taking up room on your driveway or in your garage? Why not turn it into a donation to support The Cure Parkinson’s Trust’s (CPT) research into a cure for Parkinson’s. Read more

Latest

Tom Isaacs Award Winner Announced

The Cure Parkinson’s Trust (CPT) and Van Andel Institute (VAI) have announced Professor Caroline Tanner as the winner of this year's Tom Isaacs Award.

Our Virtual Rallying to The Challenge Meeting – ‘When and How Does Parkinson’s Begin?’

For the first time, this year's meeting for people with Parkinson's, was held online and focussed on the origins and development of Parkinson’s, including triggers, early symptoms and stages of the disease.

Prasinezumab shows signs of slowing motor symptom decline in early stage Parkinson’s

Earlier this year the results of a major clinical trial - called the PASADENA study - were announced. The study was testing an immunotherapy treatment targeting alpha-synclein in people with Parkinson's. The results indicated that the trial had not achieved a positive result based on a predetermined measure of success, but the investigators indicated that there were ‘signals of efficacy‘ in the data and some of these were shared at the 2020 Movement Disorder Society meeting.

The John Black Charitable Foundation joins International Linked Clinical Trials programme as third funding partner

The Cure Parkinson’s Trust (CPT) and Van Andel Institute (VAI) are delighted to welcome a third strategic funding partner, The John Black Charitable Foundation (JBCF), to the International Linked Clinical Trials (iLCT) programme. Together, these three partners have pledged a total of USD $6.75 million to Parkinson’s research, over three years.

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.

Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.

New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut...

Science news

Read the latest Parkinson's science and research news here.

Trials - Repurposed Drugs

Our International Linked Clinical Trials initiative (iLCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.

Apply for Funding

The NAC Trial - the facts

Our story

Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.